| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 1.550 | 15.230 | - | - | - | - | - | - | - |
| Total Income - EUR | 0 | 1.550 | 17.857 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 460 | 1.711 | 18.721 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -460 | -161 | -864 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -460 | -208 | -1.321 | - | - | - | - | - | - | - |
| Employees | 0 | 0 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Karlamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 188 | 186 | 183 | - | - | - | - | - | - | - |
| Current Assets | 24.778 | 24.980 | 8.157 | - | - | - | - | - | - | - |
| Inventories | 19.587 | 18.016 | 2.627 | - | - | - | - | - | - | - |
| Receivables | 5.166 | 6.929 | 1.738 | - | - | - | - | - | - | - |
| Cash | 25 | 35 | 3.792 | - | - | - | - | - | - | - |
| Shareholders Funds | -43.415 | -43.180 | -43.770 | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | - | - | - | - | - | - | - |
| Debts | 68.381 | 68.346 | 52.110 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Karlamed S.r.l.